A muscle relaxing-drug and inhibitors of the metabolic enzyme CYP1A2 interact to cause severely low blood pressure and should not be co-prescribed, Vanderbilt investigators caution.

New discoveries by Jason MacGurn and colleagues further understanding of the complex machinery that cells use take up substances from outside the cell.

With the aid of a four-year, $3.4 million grant from the National Institute of Mental Health, researchers at Vanderbilt University Medical Center and Massachusetts General Hospital (MGH) will apply new techniques to investigate treatment resistance of two devastating mental disorders — major depressive disorder, which befalls 15 percent of people at some point in their lives, and schizophrenia, which affects approximately 1 percent.

Tom Deweese can keep up with his grandchildren because of a highly specialized surgery using hot chemotherapy that saved his leg.

Speakers at the inaugural SCRIPS Spring Symposium (Supporting Careers in Research for Interventional Physicians and Surgeons) last week were, from left, Kelle Moley, MD, senior vice president and chief scientific officer of the March of Dimes; 2018 SCRIPS Scholars Yash Choksi, MD, and Akshitkumar Mistry, MD; and Anil Rustgi, MD.

Prostate cancer patients in Nashville and Los Angeles are benefiting from a computer-based decision aid that implements the latest study results to tailor treatment options to an individual’s quality-of-life priorities.

Vanderbilt Stallworth Rehabilitation Hospital is celebrating its 25th anniversary.